Clinical Trials Browser

Phase 2/3 × OTHER × Celecoxib × Clear all

Mouth Neoplasms

NCT00027976 2013-08-05

Celecoxib in Preventing Skin Cancer in Patients With Actinic Keratoses

Phase 2/3 Withdrawn

DermatologicOther neoplasm

Precancerous Conditions, Keratosis, Actinic

NCT00808743 2013-05-16

PreDuoFAP

Phase 2/3 Completed

37 enrolled

Gastrointestinal

Adenoma, Digestive System Diseases, Digestive System Neoplasms, Duodenal Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplastic Syndromes, Hereditary, Adenomatous Polyposis Coli, Polyps, Adenomatous Polyps, Genetic Diseases, Inborn

NCT00136487 2009-12-09

Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate Cancer

Phase 2/3 Completed

85 enrolled

Genitourinary

Prostatic Neoplasms

Clinical Trials

A Study of High-Risk Oral Cavity Cancer

Celecoxib in Preventing Skin Cancer in Patients With Actinic Keratoses

PreDuoFAP

Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate Cancer